Prevalence, Risk Factors, and Clinical Characteristics of Lipodystrophy in Insulin-Treated Patients with Diabetes: An Old Problem in a New Era of Modern Insulin.

Thewjitcharoen YotsaponHussamon PrasartkaewPhatharaporn TongsumritSaruda WongjomChatnapa BoonchooSiriwan ButadejSoontaree NakasatienKrittadhee KarndumriVeekij VeerasomboonsinSirinate KrittiyawongThep Himathongkam

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)

Insulin-induced lipodystrophy is still an overlooked complication in the conundrum of diabetes care. The presence of lipodystrophy was significantly associated with the occurrence of unexplained hypoglycemia. It should be emphasized to recognize this condition by inspecting and palpating insulin injecting sites regularly, and educate patients to avoid the development of lipodystrophy.

Keyphrases

type diabetes
glycemic control
risk factors
end stage renal disease
newly diagnosed
ejection fraction
risk assessment
peritoneal dialysis
diabetic rats
oxidative stress
adipose tissue
patient reported outcomes
weight loss